189 results
Page 6 of 10
8-K
EX-10.3
6efrntzsg0oib zjkh
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
EX-2.1
xef67
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
EX-10.2
j15ozui0 qohto
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
425
r3i f691owdxn0ecy
24 Jun 20
Business combination disclosure
4:03pm
425
3zs1 r65x
22 Jun 20
Business combination disclosure
5:30pm
8-K
EX-99.2
hid9kcpw
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.3
uqnldk2t
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.4
h286fduo
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.1
ip0r4rbqkxttv0nof3
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.1
2uhb5t6j2cy fsryja4q
5 May 20
Invitae Reports More Than $64 Million in Revenue Driven by More Than 154,000 Samples Accessioned in the First Quarter of 2020
4:11pm
S-3ASR
4fix7wkgff50 2qj
20 Apr 20
Automatic shelf registration
4:59pm
S-3ASR
m140ygsj0r982
20 Apr 20
Automatic shelf registration
4:55pm
8-K
EX-99.1
qdsh56v 5yoro8
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm
8-K
66s3pn jnojisbkqighn
1 Apr 20
Regulation FD Disclosure
4:39pm
8-K
EX-99.1
8iq4e6208 d8lzrn01i
1 Apr 20
Invitae Announces Proposed Public Offering of Common Stock
4:34pm
8-K
v7d ixo0qbnp2vfsno1v
1 Apr 20
Invitae Announces Proposed Public Offering of Common Stock
4:34pm
S-3ASR
13tc ka2w
18 Mar 20
Automatic shelf registration
10:00pm